In September, the Senate passed the Children’s Public Health Act of 2000, which includes important provisions that address the study of and search for a cure for type 1 diabetes.
Spearheaded by Senator Susan Collins (R-ME), the provisions of the Act were introduced in a separate measure, The Pediatric Diabetes Research and Prevent Act, on July 17.
The Children’s Public Health Act of 2000 provides for, among other things:
- a national effort to discover preventive and curative measures for type 1 diabetes, including a vaccine
- establishing long-term studies for people with type 1 diabetes at the National Institutes of Health, where individuals will be monitored for ten years or more
- directing the Secretary of Health and Human Services, acting through the Director of the NIH, to create a national program supporting regional clinical centers to study children with type 1 diabetes.
- creating a monitoring system to more precisely estimate how many people in the United States have diabetes, observe any complications and determine the incidence and prevalence of type 1.
The remainder of the Children’s Public Health Act of 2000 provides for many important health measures for children, including maternal and infant health, injury prevention, pediatric health promotion and pediatric research.
“Senator Collins is a true leader in the fight to find a cure for diabetes,” said Peter Van Etten, president and CEO of the Juvenile Diabetes Research Foundation International. “Her unrelenting perseverance and enthusiasm in working to ensure the inclusion of juvenile diabetes in the Children’s Public Health Act of 2000 should be applauded and will help make finding a cure for diabetes a national priority.”
In 1999, Senator Collins also founded the Senate Diabetes Caucus after meeting a constituent who was struggling with diabetes and its complications. She has also chaired and co-chaired numerous hearings on diabetes.